Phase I Safety Trial: As noted, a Phase I trial (the first step in testing a drug in humans, usually focused on safety and pharmacokinetics) was registered in 2015, aiming to give BPC-157 to healthy volunteers
In non-small cell lung carcinoma, there are varying levels of FOXO4 expressed that correspond to how the cancer was staged
In doing so, you will have guaranteed the lifespan of your vials
Ongoing Monitoring As your body responds, your provider may adjust your protocol, dosing, frequency, or supportive care recommendations
The 2025 paper is the most recent significant independent confirmation of the in vitro mechanistic claims about Epithalon and represents the kind of external replication that the Epithalon literature had previously lacked